Katherine Williams, MD
Obstetrics & Gynecology · Covington, LANPI 1851363550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$963
- AbbVie$556
- Millicent US Inc$369
- Evofem Biosciences, Inc.$339
- Novo Nordisk$264
- Avion Pharmaceuticals$252
- plus $3K from 42 others
Across 3 payments — averaging $3048.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Innovation$9K
- Novo Nordisk AS$100
What the payments were for
- Travel & lodging$2133%
- Food & beverage$5,74494%
- Education$1212%
- Gifts$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,105 in reported general payments places this provider in the 90th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 28 | $3,352 |
| Estradiol | 26 | $2,275 |
| ProgesteroneProgesterone, Micronized | 56 | $1,729 |
| Clobetasol Propionate | 18 | $731 |
| Buspirone Hcl | 14 | $138 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Covington
- Julie LandryCovington$9K
- Jamie HymelCovington$7K
- Kelly BrewsterCovington$7K
- Daniel MokryCovington$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.